Epinex Diagnostics, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Epinex Diagnostics operates in the biotechnology research sector, developing rapid diagnostic tests intended for use at clinics and home settings. The company leverages existing technologies to create quantitative tests suitable for point-of-care and over-the-counter use. Its flagship product, the G1A Rapid Diabetes Monitoring Index Test, is a patented monthly diabetes monitoring assay. Based in Tustin, California, the firm sits within the Southern California biomedical cluster, adjacent to the University of California, Irvine. As a small to mid-sized enterprise, it focuses on bringing rapid testing solutions to healthcare providers and individuals seeking convenient diabetes monitoring. In late 2016, Epinex announced the launch of the Am I Diabetic app.